Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2025-12-25 @ 12:34 AM
NCT ID:
NCT03216967
Eligibility Criteria:
Inclusion Criteria:
* Adult patients
* Kidney transplant recipients
* Patients treated by a calcineurin inhibitor and mycophenolic acid
* Viremia \>= 2.8 log UI/ml
* Patients who have given written informed consent
* Negative pregnancy test (blood β-HCG dosage)
Exclusion Criteria:
* Known proved BKV nephropathy
* Hypersensitivity to everolimus, sirolimus or excipient
* Concomitant treatment by leflunomide, cidofovir, sirolimus, Millepertuis (Hypericum Perforatum)
* Pregnant or lactating women
* Women of child bearing potential unless they are using a birth control method
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03216967
Study Brief:
Protocol Section:
NCT03216967